¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Quick Dissolve Maalox Max Maximum Strength Antacid/ Antig..."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • maximum expiratory flow rate
    ÃÖ°í³¯¼ûÀ¯¼Ó, ÃÖ°íÈ£±âÀ¯¼Ó
  • maximum flow rate
    1. ÃÖ°íÀ¯¼Ó 2. ÃÖ°íÈ帧¼Óµµ 3. ÃÖ´ëÀ¯·®
  • maximum heart rate
    ÃÖ´ë½ÉÀå¹Úµ¿¼ö, ÃÖ´ë½É¹Ú¼ö
  • maximum intensity projection
    ÃÖ´ë°­µµÅõ»ç
  • maximum midexpiratory flow
    ÃÖ´ëÁß°£³¯¼ûÀ¯·®, ÃÖ´ëÁß°£È£±âÀ¯·®
  • maximum oxygen debt
    ÃÖ´ë»ê¼ÒºÎä
  • maximum permissible concentration
    ÃÖ´ëÇã¿ë³óµµ
  • maximum permissible level
    ÃÖ´ëÇã¿ë¼öÁØ
  • maximum permissible limit
    ÃÖ´ëÇã¿ëÇѰè
  • maximum phonation time
    ÃÖÀå¹ß¼ºÁö¼Ó½Ã°£
  • maximum power output
    ÃÖ´ëÃâ·Â
  • maximum safe intensity level
    ÃÖ´ë¾ÈÀü°­µµ¼öÁØ
  • maximum security unit
    ÃÖ´ë¾ÈÀüº´µ¿
  • maximum tolerance dose
    1. ÃÖ´ë³»¾à¿ë·®, ÃÖ´ë³»¾à·® 2. ÃÖ´ë°ßµõ¼±·®
  • maximum urea clearance
    ÃÖ°í¿ä¼Òû¼Ò, ÃÖ°í¿ä¼Òû¼ÒÀ²
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • maximum allowable concentration
    ÃÖ´ëÇã¿ë³óµµ
  • maximum permissible concentration
    ÃÖ´ëÇã¿ë³óµµ
  • maximum urea clearance
    ÃÖ°í¿ä¼Òû¼Ò, ÃÖ°í¿ä¼Òû¼ÒÀ²
  • maximum dose
    ÃÖ´ë¿ë·®, ÃÖ´ë¼±·®
  • maximum allowable dose
    ÃÖ´ëÇã¿ë·®
  • maximum oxygen debt
    ÃÖ´ë»ê¼ÒºÎä·®
  • maximum tolerance dose
    ÃÖ´ë³»¾à¿ë·®, ÃÖ´ë³»¾à·®, ÃÖ´ë°ßµõ¼±·®
  • maximum midexpiratory flow
    Ãִ볯¼ûÁß°£À¯·®
  • maximum acceptable daily intake
    ÀÏÀϼ·ÃëÃÖ´ëÇã¿ë·®
  • maximum allowable limit
    ÃÖ´ëÇã¿ëÇѰè
  • maximum permissible level
    ÃÖ´ëÇã¿ë¼öÁØ
  • maximum permissible limit
    ÃÖ´ëÇã¿ëÇѰè
  • maximum safe intensity level
    ÃÖ´ë¾ÈÀü°­µµ¼öÁØ
  • maximum
    ÃÖ´ë
  • maximum transport
    ÃÖ´ë¿î¹ÝÄ¡, ÃÖ´ëÀ̵¿Ä¡
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • tensile strength
    ½ÅÀå°­µµ(ãßíåË­öô)
  • tinting strength
    Âø»ö·Â(ó·ßäæ³).
  • ultimate strength
    ±ØÇѰ­µµ(пùÚË­öô) ¡ìÀç·áÀÇ¡í.
  • wet strength
    ½ÀÀ±µµ(ã¥ëÈöô), ½À°­µµ (ã¥Ë­öô).
  • wound strength
    â»ó°­µµ, â»ó¼¼±â, â»óÈû
  • yield strength
    Ç׺¹°­µµ(ú¢ÜÑË­öô).
  • apex beat =point of maximum impulse
    ½É÷¹Úµ¿(ãýôÓÚÑÔÑ)
  • articulation score, maximum
    ÃÖ°í¸í·áµµ
  • discrimination score, maximum
    ÃÖ´ë¸í·áÄ¡
  • maximum absorption
    ÃÖ´ëÈí¼ö.
  • maximum acceptable daily intake =MADI
    ÀÏÀϼ·ÃëÃÖ´ëÇã¿ë·®(ìéìíàîö¢õÌÓÞúÉé»åÖ).
  • maximum acceptable daily intake =MADI
    ÀÏÀϼ·ÃëÃÖ´ëÇã¿ë·®(ËöËöËÛ̧̬ËÀÌ´ËíËâ).
  • maximum acid output
    ÃÖ´ë»ê¹èÃâ·®
  • maximum acid output
    ÃÖ´ë»êºÐºñ·®(õÌÓÞß«ÝÂù²åÖ).
  • maximum allowable concentration =MAC
    ÃÖ´ëÇã¿ë³óµµ(õÌÓÞúÉé»ÒØöô).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
QF quality factor; query fever; quick freeze; relative biological effectiveness
QMR quick medical reference
QT cardiac output; Quick test
Dmax maximum denaturation; maximum diameter
MAC MacConkey [broth]; major ambulatory category; malignancy-associated changes; maximum allowable conce...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
IS Ionic Strength
LISS Low ionic strength solutions
RMS Respiratory muscle strength
SBS Shear bond strength
ST Strength training
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • maximum expiratory flow rate
    ÃÖ´ë È£±â À¯·®·ü
  • maximum foundation plane
    ÀÇÄ¡»ó Æò±Õ Àú¸é
  • maximum intercuspal contact
    ÃÖ´ë ±³ÇÕ Á¢ÃË
  • maximum intercuspation
    ÃÖ´ë ±³µÎ°£À§, ÃÖ´ë ±³µÎ °¨ÇÕ, ÃÖ´ë ±³ÇÕ
    »ó, ÇÏ¾Ç Ä¡¾ÆÀÇ ±³µÎµéÀÌ °¡Àå ¸¹ÀÌ Á¢ÃËÇÏ´Â °Í.
  • maximum mid-expiratory flow rate
    ÃÖ´ë Áß°£ È£±â À¯Ãâ ¼Óµµ
  • maximum oxygen consumption
    ÃÖ´ë »ê¼Ò ¼Ò¸ð·®
  • maximum permissible concentration
    ÃÖ´ë Çã¿ë ³óµµ
  • maximum permissible exposure
    ÃÖ´ë Çã¿ë ³ëÃâ
  • maximum permissible limit
    ÃÖ´ë Çã¿ë ÇѰè
  • maximum point of opening
    ÃÖ´ë °³±¸À§
  • maximum rotation of the joint
    °üÀýÀÇ ÃÖ´ë ȸÀü ¿îµ¿·®
  • maximum security unit
    ÃÖ´ë ¾ÈÀü º´µ¿
  • maximum surgical blood order schedule
    ÃÖ´ë ¼ö¼ú Ç÷¾× ¿äû ¿¹Á¤Ç¥
  • maximum tolerance dose
    ÃÖ´ë ³»¿ë·®, ÃÖ´ë °ßµõ ¼±·®
  • maximum urethral closure pressure
    ÃÖ°í ¿äµµ Æó¼â¾Ð
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
Bockhart, Max <person> German physician, 1883-1921.
See: Bockhart's impetigo.
(05 Mar 2000)
Burger, Max <person> German physician, *1885.
See: Burger-Grutz syndrome, Burger-Grutz disease.
(05 Mar 2000)
Madlener, Max <person> German surgeon, 1868-1951.
See: Madlener operation.
(05 Mar 2000)
Max Transcription factor: forms homodimers which then interact with CACGTG motif of DNA repressively, but will form heterodimers with Myc that bind the same motif with greater affinity and activate the downstream gene.
(18 Nov 1997)
Gruber, Max von <person> German hygienist, 1853-1927.
See: Gruber's reaction, Gruber-Widal reaction.
(05 Mar 2000)
Gutzeit, Max <person> German chemist, 1847-1915.
See: Gutzeit's test.
(05 Mar 2000)
Clara, Max <person> Austrian anatomist, *1899.
See: Clara cell.
(05 Mar 2000)
Wachstein, Max <person> U.S. Histologist and pathologist, 1905-1965.
See: Wachstein-Meissel stain for calcium-magnesium-ATPase.
(05 Mar 2000)
Walthard, Max <person> Swiss gynecologist, 1867-1933.
See: Walthard's cell rest.
(05 Mar 2000)
Planck, Max <person> German physicist and Nobel laureate, 1858-1947.
See: Planck's constant, Planck's theory.
(05 Mar 2000)
Wilms, Max <person> German surgeon, 1867-1918.
See: Wilms' tumour.
(05 Mar 2000)
Winkler, Max <person> Swiss physician, 1875-1952.
See: Winkler's disease.
(05 Mar 2000)
Schultze, Max <person> German histologist and zoologist, 1825-1874.
See: Schultze's cells, Schultze's membrane, Schultze's sign, comma bundle of Schultze, comma tract of Schultze.
(05 Mar 2000)
Huhner, Max <person> U.S. Urologist, 1873-1947.
See: Huhner test.
(05 Mar 2000)
Neisser, Max <person> German bacteriologist, 1869-1938.
See: Neisser's stain.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á